Sorry, you need to enable JavaScript to visit this website.
Please rate this episode
Congratulations!

You have now completed all the episodes in this season.

Complete the knowledge check to gain 1 CPD credit.

The use of this website is intended for healthcare professionals based in the UK.

Please confirm you are a member of the intended audience below:

Do you want to leave Masterclass TV?

By clicking yes below, you will leave www.masterclasstv.co.uk and be redirected to another website.

Links to external websites are provided as a resource to the viewer. This website is neither owned or controlled by the BMS/Pfizer Ltd Alliance. Neither BMS nor Pfizer accept responsibility for the content or services of the linked site.

YES

Do you want to leave Masterclass TV?

By clicking yes below, you will leave www.masterclasstv.co.uk and be redirected to another website.

YES
Skip to main content

This information is intended for healthcare professionals based in the UK. 
If you are not a healthcare professional in the UK, click here. 
For more information on Vydura ▼(rimegepant), please visit www.pfizerpro.co.uk

A promotional initiative developed and funded by Pfizer Ltd

PRESCRIBING INFORMATION FOR VYDURA (RIMEGEPANT)

Adverse event reporting information can be found at the bottom of the page

PRESCRIBING INFORMATION FOR VYDURA (RIMEGEPANT)

Adverse event reporting information can be found at the bottom of the page

Welcome to Migraine
Dialogues TV

Migraine Dialogues TV is a promotional medical education programme – developed and funded by Pfizer Ltd – intended to support excellence in clinical practice among healthcare professionals involved in the diagnosis, treatment and management of migraine.

Registering for Migraine Dialogues TV will provide you with access to PfizerPro.co.uk where you can explore Pfizer medicines, therapy areas and upcoming events. Users who are already registered on PfizerPro will also gain access to Migraine Dialogues TV using their current login details.

I am a UK Healthcare professionalI'm a member of the general public based in the UK

To exercise any data privacy rights that you may have, as well as to raise any concerns or questions in relation to the handling of your personal data by Pfizer please contact us at [email protected], or write to the following address: Pfizer Limited, IPC 1-1, Walton Oaks, Dorking Road, Tadworth, Surrey KT20 7NS

Adverse events should be reported.

Reporting forms and information can be found at https://yellowcard.mhra.gov.uk or search for MHRA Yellow Card in Google Play or Apple App Store.

Adverse events should also be reported to Pfizer Medical Information on 01304 616161

All corporate names and logos of Pfizer and/or of its products are trademarks of Pfizer and are protected by national and international intellectual and industrial property laws. All rights reserved over the content of this website.

Copyright © 2025 Pfizer Limited. All rights reserved. Registered in England and Wales No. 526209. Registered office: Ramsgate Road, Sandwich, Kent CT13 9NJ. VAT No. GB201048427

Your use of this website is subject to the Terms of Use, the Privacy and Cookie Policy, the Pharmacovigilance Notice and the applicable laws and regulations

  • Privacy policy
  • Terms of use
  • Pharmacovigilance Notice
  • Cookie policy
  • Contact Pfizer
PP-NNT-GBR-2719 | March 2025
©2025 Pfizer | All rights reserved